Organization
University of Cambridge, Department of Medicine, Cambridge, United Kingdom
2 abstracts
Abstract
A RANDOMIZED, CONTROLLED TRIAL OF RITUXIMAB VERSUS AZATHIOPRINE AFTER INDUCTION OF REMISSION WITH RITUXIMAB FOR PATIENTS WITH ANCA-ASSOCIATED VASCULITIS AND RELAPSING DISEASEOrg: University of Cambridge, Department of Medicine, Cambridge, United Kingdom, University of Cambridge, Cambridge, United Kingdom, University of Pennsylvania, Philadelphia, United States of America,
Abstract
BENRALIZUMAB FOR EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA): RESULTS FROM A EUROPEAN MULTICENTER STUDY ON 121 PATIENTSOrg: University of Florence, Department of Experimental and Clinical Medicine, Florence, Italy, University of Padova, Department of Medicine DIMED, Padova, Italy, Hôpital Foch, Department of Internal Medicine, Suresnes, France, University of Bari, Department of Precision and Rigenerative Medicine and Ionian Area, Bari, Italy, Addenbrookes Hospital, Department of Medicine, Cambridge, United Kingdom,